Franklin Resources
AMLX icon

Franklin Resources’s Amylyx Pharmaceuticals AMLX Stock Holding History

Franklin Resources’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53M Buy
2,950,225
+688,656
+30% +$10.7M 0.01% 657
2026
Q1 		$31.4M Buy
2,261,569
+1,061,473
+88% +$14.9M 0.01% 800
2025
Q4 		$14.5M Buy
+1,200,096
New +$16.3M ﹤0.01% 1053
2024
Q2 		– Sell
-1,855,886
Closed -$5.27M – 2869
2024
Q1 		$5.27M Buy
1,855,886
+530,885
+40% +$6.94M ﹤0.01% 1305
2023
Q4 		$19.5M Buy
1,325,001
+707,134
+114% +$10.8M 0.01% 759
2023
Q3 		$11.3M Buy
617,867
+589,381
+2,069% +$12.5M 0.01% 886
2023
Q2 		$614K Buy
+28,486
New +$769K ﹤0.01% 1882

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Franklin Resources's AMLX Position: Q2 2026 in Review

Franklin Resources increased its Amylyx Pharmaceuticals (AMLX) stake by 30% in Q2 2026, buying an estimated $10.7M and bringing the position to 2,950,225 shares worth $53M. The position accounts for 0.01% of the portfolio, ranked #657.

Franklin Resources first reported a position in AMLX in Q2 2023 and has held it in 7 quarters since. 207 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Franklin Resources held 2,950,225 shares of Amylyx Pharmaceuticals worth $53M as of Q2 2026.
  • Franklin Resources bought 688,656 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $10.7M.
  • Amylyx Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #657 holding.
  • Franklin Resources first reported a position in Amylyx Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • 207 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.